This result is based on the ability of PDGF and other molecules produced by MSC to activate the PI3K/Akt/mTOR pathway, and thus to upregulate mTOR signaling; the latter one appears to be decreased in several eye diseases [205]. This evidence concerns the gene MTOR and eye disorder.